| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 1 | GB 1 | 99.88 |
| Vasculitis and related conditions | Lifetime | 1 | GB 1 | 99.96 |
| Urticaria and Related Conditions | Lifetime | 2 | GB 1 | 99.82 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 1 | GB 1 | 99.95 |
| Renal Diseases and Glomerulopathies | Lifetime | 9 | GB 1 | 99.82 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 3 | GB 2 | 99.86 |
| Systemic Lupus Erythematosus Research | Lifetime | 32 | GB 7 | 99.78 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 9 | GB 1 | 99.58 |
| Eosinophilic Disorders and Syndromes | Lifetime | 185 | GB 19 | 98.43 |
| Inflammasome and immune disorders | Lifetime | 216 | GB 17 | 97.71 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 216 | GB 16 | 97.91 |
| Liver Diseases and Immunity | Lifetime | 210 | GB 20 | 98.21 |
| Cell Adhesion Molecules Research | Lifetime | 794 | GB 75 | 97.73 |
| Kawasaki Disease and Coronary Complications | Lifetime | 143 | GB 8 | 96.78 |
| Systemic Sclerosis and Related Diseases | Lifetime | 389 | GB 36 | 97.13 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 449 | GB 28 | 97.04 |
| Platelet Disorders and Treatments | Lifetime | 602 | GB 45 | 96.99 |
| Complement system in diseases | Lifetime | 374 | GB 43 | 96.65 |
| Autoimmune Bullous Skin Diseases | Lifetime | 950 | GB 76 | 94.27 |
| Blood disorders and treatments | Lifetime | 771 | GB 62 | 92.75 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 525 | GB 26 | 86.97 |
| Vasculitis and related conditions | 2021-2025 | 1 | GB 1 | 99.93 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 2 | GB 1 | 99.79 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 21 | GB 2 | 99.26 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 4 | GB 1 | 98.89 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 15 | GB 2 | 98.56 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 51 | GB 5 | 98.70 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 11 | GB 1 | 98.56 |
| Urticaria and Related Conditions | 2021-2025 | 36 | GB 1 | 98.17 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 48 | GB 3 | 97.57 |
| Inflammasome and immune disorders | 2021-2025 | 356 | GB 12 | 90.03 |
| Complement system in diseases | 2021-2025 | 343 | GB 33 | 84.25 |
| Platelet Disorders and Treatments | 2021-2025 | 862 | GB 78 | 80.37 |
